nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—SLCO1B3—Paclitaxel—ovarian cancer	0.192	0.252	CbGbCtD
Gadoxetate—SLCO1B3—Docetaxel—ovarian cancer	0.139	0.182	CbGbCtD
Gadoxetate—ABCC3—Doxorubicin—ovarian cancer	0.117	0.153	CbGbCtD
Gadoxetate—ABCC2—Paclitaxel—ovarian cancer	0.0983	0.129	CbGbCtD
Gadoxetate—ABCC2—Carboplatin—ovarian cancer	0.0925	0.121	CbGbCtD
Gadoxetate—ABCC2—Docetaxel—ovarian cancer	0.0711	0.0932	CbGbCtD
Gadoxetate—ABCC2—Doxorubicin—ovarian cancer	0.053	0.0695	CbGbCtD
Gadoxetate—ABCC3—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	0.000294	0.0689	CbGpPWpGaD
Gadoxetate—Tremor—Paclitaxel—ovarian cancer	0.000294	0.00126	CcSEcCtD
Gadoxetate—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000291	0.00125	CcSEcCtD
Gadoxetate—Renal impairment—Doxorubicin—ovarian cancer	0.000289	0.00124	CcSEcCtD
Gadoxetate—Agitation—Paclitaxel—ovarian cancer	0.000288	0.00123	CcSEcCtD
Gadoxetate—Face oedema—Epirubicin—ovarian cancer	0.000287	0.00123	CcSEcCtD
Gadoxetate—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000284	0.00122	CcSEcCtD
Gadoxetate—Cardiac disorder—Docetaxel—ovarian cancer	0.000283	0.00121	CcSEcCtD
Gadoxetate—Flushing—Docetaxel—ovarian cancer	0.000283	0.00121	CcSEcCtD
Gadoxetate—Vomiting—Topotecan—ovarian cancer	0.000283	0.00121	CcSEcCtD
Gadoxetate—Malaise—Paclitaxel—ovarian cancer	0.000283	0.00121	CcSEcCtD
Gadoxetate—Vertigo—Paclitaxel—ovarian cancer	0.000281	0.00121	CcSEcCtD
Gadoxetate—Syncope—Paclitaxel—ovarian cancer	0.000281	0.0012	CcSEcCtD
Gadoxetate—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.000281	0.0012	CcSEcCtD
Gadoxetate—Rash—Topotecan—ovarian cancer	0.00028	0.0012	CcSEcCtD
Gadoxetate—Hypersensitivity—Vinorelbine—ovarian cancer	0.00028	0.0012	CcSEcCtD
Gadoxetate—Dermatitis—Topotecan—ovarian cancer	0.00028	0.0012	CcSEcCtD
Gadoxetate—Blood creatinine increased—Epirubicin—ovarian cancer	0.000279	0.00119	CcSEcCtD
Gadoxetate—Headache—Topotecan—ovarian cancer	0.000278	0.00119	CcSEcCtD
Gadoxetate—Palpitations—Paclitaxel—ovarian cancer	0.000277	0.00119	CcSEcCtD
Gadoxetate—Angiopathy—Docetaxel—ovarian cancer	0.000277	0.00119	CcSEcCtD
Gadoxetate—Vomiting—Melphalan—ovarian cancer	0.000277	0.00119	CcSEcCtD
Gadoxetate—Dehydration—Epirubicin—ovarian cancer	0.000277	0.00119	CcSEcCtD
Gadoxetate—Immune system disorder—Docetaxel—ovarian cancer	0.000276	0.00118	CcSEcCtD
Gadoxetate—Loss of consciousness—Paclitaxel—ovarian cancer	0.000275	0.00118	CcSEcCtD
Gadoxetate—Mediastinal disorder—Docetaxel—ovarian cancer	0.000275	0.00118	CcSEcCtD
Gadoxetate—Rash—Melphalan—ovarian cancer	0.000274	0.00118	CcSEcCtD
Gadoxetate—Dermatitis—Melphalan—ovarian cancer	0.000274	0.00117	CcSEcCtD
Gadoxetate—Chills—Docetaxel—ovarian cancer	0.000274	0.00117	CcSEcCtD
Gadoxetate—Cough—Paclitaxel—ovarian cancer	0.000273	0.00117	CcSEcCtD
Gadoxetate—Asthenia—Vinorelbine—ovarian cancer	0.000273	0.00117	CcSEcCtD
Gadoxetate—Arrhythmia—Docetaxel—ovarian cancer	0.000273	0.00117	CcSEcCtD
Gadoxetate—Convulsion—Paclitaxel—ovarian cancer	0.000271	0.00116	CcSEcCtD
Gadoxetate—Hypokalaemia—Epirubicin—ovarian cancer	0.000271	0.00116	CcSEcCtD
Gadoxetate—Pruritus—Vinorelbine—ovarian cancer	0.000269	0.00115	CcSEcCtD
Gadoxetate—Chest pain—Paclitaxel—ovarian cancer	0.000267	0.00114	CcSEcCtD
Gadoxetate—Anxiety—Paclitaxel—ovarian cancer	0.000266	0.00114	CcSEcCtD
Gadoxetate—Face oedema—Doxorubicin—ovarian cancer	0.000266	0.00114	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000265	0.00114	CcSEcCtD
Gadoxetate—Nausea—Topotecan—ovarian cancer	0.000264	0.00113	CcSEcCtD
Gadoxetate—Discomfort—Paclitaxel—ovarian cancer	0.000264	0.00113	CcSEcCtD
Gadoxetate—Dry mouth—Paclitaxel—ovarian cancer	0.000261	0.00112	CcSEcCtD
Gadoxetate—Diarrhoea—Vinorelbine—ovarian cancer	0.00026	0.00111	CcSEcCtD
Gadoxetate—Dysgeusia—Docetaxel—ovarian cancer	0.00026	0.00111	CcSEcCtD
Gadoxetate—Abdominal distension—Epirubicin—ovarian cancer	0.000259	0.00111	CcSEcCtD
Gadoxetate—Nausea—Melphalan—ovarian cancer	0.000258	0.00111	CcSEcCtD
Gadoxetate—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000258	0.0011	CcSEcCtD
Gadoxetate—Dysphagia—Epirubicin—ovarian cancer	0.000257	0.0011	CcSEcCtD
Gadoxetate—Back pain—Docetaxel—ovarian cancer	0.000257	0.0011	CcSEcCtD
Gadoxetate—Dehydration—Doxorubicin—ovarian cancer	0.000256	0.0011	CcSEcCtD
Gadoxetate—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000256	0.0011	CcSEcCtD
Gadoxetate—Oedema—Paclitaxel—ovarian cancer	0.000256	0.0011	CcSEcCtD
Gadoxetate—Infection—Paclitaxel—ovarian cancer	0.000254	0.00109	CcSEcCtD
Gadoxetate—Shock—Paclitaxel—ovarian cancer	0.000252	0.00108	CcSEcCtD
Gadoxetate—Dizziness—Vinorelbine—ovarian cancer	0.000251	0.00108	CcSEcCtD
Gadoxetate—Nervous system disorder—Paclitaxel—ovarian cancer	0.000251	0.00107	CcSEcCtD
Gadoxetate—Hypokalaemia—Doxorubicin—ovarian cancer	0.00025	0.00107	CcSEcCtD
Gadoxetate—Tachycardia—Paclitaxel—ovarian cancer	0.00025	0.00107	CcSEcCtD
Gadoxetate—Skin disorder—Paclitaxel—ovarian cancer	0.000248	0.00106	CcSEcCtD
Gadoxetate—Bronchitis—Epirubicin—ovarian cancer	0.000247	0.00106	CcSEcCtD
Gadoxetate—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000247	0.00106	CcSEcCtD
Gadoxetate—Anorexia—Paclitaxel—ovarian cancer	0.000244	0.00104	CcSEcCtD
Gadoxetate—Vomiting—Vinorelbine—ovarian cancer	0.000242	0.00104	CcSEcCtD
Gadoxetate—Rash—Vinorelbine—ovarian cancer	0.00024	0.00103	CcSEcCtD
Gadoxetate—Dermatitis—Vinorelbine—ovarian cancer	0.000239	0.00103	CcSEcCtD
Gadoxetate—Abdominal distension—Doxorubicin—ovarian cancer	0.000239	0.00103	CcSEcCtD
Gadoxetate—Hypotension—Paclitaxel—ovarian cancer	0.000239	0.00102	CcSEcCtD
Gadoxetate—Headache—Vinorelbine—ovarian cancer	0.000238	0.00102	CcSEcCtD
Gadoxetate—Syncope—Docetaxel—ovarian cancer	0.000238	0.00102	CcSEcCtD
Gadoxetate—Dysphagia—Doxorubicin—ovarian cancer	0.000238	0.00102	CcSEcCtD
Gadoxetate—Palpitations—Docetaxel—ovarian cancer	0.000235	0.00101	CcSEcCtD
Gadoxetate—Loss of consciousness—Docetaxel—ovarian cancer	0.000233	0.001	CcSEcCtD
Gadoxetate—ABCC2—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	0.000233	0.0546	CbGpPWpGaD
Gadoxetate—Cough—Docetaxel—ovarian cancer	0.000232	0.000993	CcSEcCtD
Gadoxetate—Convulsion—Docetaxel—ovarian cancer	0.00023	0.000986	CcSEcCtD
Gadoxetate—Paraesthesia—Paclitaxel—ovarian cancer	0.00023	0.000984	CcSEcCtD
Gadoxetate—Bronchitis—Doxorubicin—ovarian cancer	0.000229	0.00098	CcSEcCtD
Gadoxetate—Dyspnoea—Paclitaxel—ovarian cancer	0.000228	0.000977	CcSEcCtD
Gadoxetate—Chest pain—Docetaxel—ovarian cancer	0.000226	0.000969	CcSEcCtD
Gadoxetate—Nausea—Vinorelbine—ovarian cancer	0.000226	0.000968	CcSEcCtD
Gadoxetate—Renal failure—Epirubicin—ovarian cancer	0.000225	0.000965	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000225	0.000962	CcSEcCtD
Gadoxetate—Conjunctivitis—Epirubicin—ovarian cancer	0.000223	0.000955	CcSEcCtD
Gadoxetate—Decreased appetite—Paclitaxel—ovarian cancer	0.000222	0.000952	CcSEcCtD
Gadoxetate—Dry mouth—Docetaxel—ovarian cancer	0.000221	0.000947	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000221	0.000946	CcSEcCtD
Gadoxetate—Fatigue—Paclitaxel—ovarian cancer	0.00022	0.000945	CcSEcCtD
Gadoxetate—SLCO1B1—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	0.000219	0.0513	CbGpPWpGaD
Gadoxetate—Constipation—Paclitaxel—ovarian cancer	0.000219	0.000937	CcSEcCtD
Gadoxetate—Anaphylactic shock—Docetaxel—ovarian cancer	0.000217	0.000929	CcSEcCtD
Gadoxetate—Oedema—Docetaxel—ovarian cancer	0.000217	0.000929	CcSEcCtD
Gadoxetate—Infection—Docetaxel—ovarian cancer	0.000215	0.000923	CcSEcCtD
Gadoxetate—Shock—Docetaxel—ovarian cancer	0.000213	0.000914	CcSEcCtD
Gadoxetate—Nervous system disorder—Docetaxel—ovarian cancer	0.000213	0.000911	CcSEcCtD
Gadoxetate—Tachycardia—Docetaxel—ovarian cancer	0.000212	0.000906	CcSEcCtD
Gadoxetate—Feeling abnormal—Paclitaxel—ovarian cancer	0.000211	0.000903	CcSEcCtD
Gadoxetate—Skin disorder—Docetaxel—ovarian cancer	0.000211	0.000902	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000209	0.000896	CcSEcCtD
Gadoxetate—Renal failure—Doxorubicin—ovarian cancer	0.000208	0.000893	CcSEcCtD
Gadoxetate—Anorexia—Docetaxel—ovarian cancer	0.000207	0.000885	CcSEcCtD
Gadoxetate—Rhinitis—Epirubicin—ovarian cancer	0.000206	0.000884	CcSEcCtD
Gadoxetate—Conjunctivitis—Doxorubicin—ovarian cancer	0.000206	0.000883	CcSEcCtD
Gadoxetate—Hypoaesthesia—Epirubicin—ovarian cancer	0.000205	0.000877	CcSEcCtD
Gadoxetate—Urticaria—Paclitaxel—ovarian cancer	0.000203	0.00087	CcSEcCtD
Gadoxetate—Hypotension—Docetaxel—ovarian cancer	0.000203	0.000868	CcSEcCtD
Gadoxetate—Connective tissue disorder—Epirubicin—ovarian cancer	0.000202	0.000866	CcSEcCtD
Gadoxetate—Abdominal pain—Paclitaxel—ovarian cancer	0.000202	0.000866	CcSEcCtD
Gadoxetate—Body temperature increased—Paclitaxel—ovarian cancer	0.000202	0.000866	CcSEcCtD
Gadoxetate—Paraesthesia—Docetaxel—ovarian cancer	0.000195	0.000834	CcSEcCtD
Gadoxetate—Dyspnoea—Docetaxel—ovarian cancer	0.000193	0.000828	CcSEcCtD
Gadoxetate—Flushing—Epirubicin—ovarian cancer	0.000191	0.000818	CcSEcCtD
Gadoxetate—Cardiac disorder—Epirubicin—ovarian cancer	0.000191	0.000818	CcSEcCtD
Gadoxetate—Rhinitis—Doxorubicin—ovarian cancer	0.000191	0.000818	CcSEcCtD
Gadoxetate—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000189	0.000812	CcSEcCtD
Gadoxetate—Decreased appetite—Docetaxel—ovarian cancer	0.000188	0.000807	CcSEcCtD
Gadoxetate—Hypersensitivity—Paclitaxel—ovarian cancer	0.000188	0.000807	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000187	0.000802	CcSEcCtD
Gadoxetate—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000187	0.000802	CcSEcCtD
Gadoxetate—Fatigue—Docetaxel—ovarian cancer	0.000187	0.000801	CcSEcCtD
Gadoxetate—Angiopathy—Epirubicin—ovarian cancer	0.000187	0.0008	CcSEcCtD
Gadoxetate—Immune system disorder—Epirubicin—ovarian cancer	0.000186	0.000796	CcSEcCtD
Gadoxetate—Mediastinal disorder—Epirubicin—ovarian cancer	0.000185	0.000795	CcSEcCtD
Gadoxetate—Constipation—Docetaxel—ovarian cancer	0.000185	0.000794	CcSEcCtD
Gadoxetate—Chills—Epirubicin—ovarian cancer	0.000185	0.000791	CcSEcCtD
Gadoxetate—Arrhythmia—Epirubicin—ovarian cancer	0.000184	0.000788	CcSEcCtD
Gadoxetate—Asthenia—Paclitaxel—ovarian cancer	0.000183	0.000786	CcSEcCtD
Gadoxetate—Pruritus—Paclitaxel—ovarian cancer	0.000181	0.000775	CcSEcCtD
Gadoxetate—Feeling abnormal—Docetaxel—ovarian cancer	0.000179	0.000765	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000177	0.000759	CcSEcCtD
Gadoxetate—Flushing—Doxorubicin—ovarian cancer	0.000177	0.000757	CcSEcCtD
Gadoxetate—Cardiac disorder—Doxorubicin—ovarian cancer	0.000177	0.000757	CcSEcCtD
Gadoxetate—Flatulence—Epirubicin—ovarian cancer	0.000177	0.000756	CcSEcCtD
Gadoxetate—Dysgeusia—Epirubicin—ovarian cancer	0.000175	0.000752	CcSEcCtD
Gadoxetate—Diarrhoea—Paclitaxel—ovarian cancer	0.000175	0.00075	CcSEcCtD
Gadoxetate—Back pain—Epirubicin—ovarian cancer	0.000173	0.000742	CcSEcCtD
Gadoxetate—Angiopathy—Doxorubicin—ovarian cancer	0.000173	0.00074	CcSEcCtD
Gadoxetate—Immune system disorder—Doxorubicin—ovarian cancer	0.000172	0.000737	CcSEcCtD
Gadoxetate—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000172	0.000735	CcSEcCtD
Gadoxetate—Abdominal pain—Docetaxel—ovarian cancer	0.000171	0.000734	CcSEcCtD
Gadoxetate—Body temperature increased—Docetaxel—ovarian cancer	0.000171	0.000734	CcSEcCtD
Gadoxetate—Chills—Doxorubicin—ovarian cancer	0.000171	0.000732	CcSEcCtD
Gadoxetate—Arrhythmia—Doxorubicin—ovarian cancer	0.00017	0.000729	CcSEcCtD
Gadoxetate—Dizziness—Paclitaxel—ovarian cancer	0.000169	0.000725	CcSEcCtD
Gadoxetate—Vision blurred—Epirubicin—ovarian cancer	0.000169	0.000723	CcSEcCtD
Gadoxetate—Ill-defined disorder—Epirubicin—ovarian cancer	0.000166	0.000712	CcSEcCtD
Gadoxetate—Agitation—Epirubicin—ovarian cancer	0.000165	0.000705	CcSEcCtD
Gadoxetate—Flatulence—Doxorubicin—ovarian cancer	0.000163	0.0007	CcSEcCtD
Gadoxetate—Vomiting—Paclitaxel—ovarian cancer	0.000163	0.000697	CcSEcCtD
Gadoxetate—Dysgeusia—Doxorubicin—ovarian cancer	0.000162	0.000695	CcSEcCtD
Gadoxetate—Malaise—Epirubicin—ovarian cancer	0.000162	0.000692	CcSEcCtD
Gadoxetate—Rash—Paclitaxel—ovarian cancer	0.000161	0.000691	CcSEcCtD
Gadoxetate—Dermatitis—Paclitaxel—ovarian cancer	0.000161	0.00069	CcSEcCtD
Gadoxetate—Vertigo—Epirubicin—ovarian cancer	0.000161	0.00069	CcSEcCtD
Gadoxetate—ABCC3—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.000161	0.0377	CbGpPWpGaD
Gadoxetate—Syncope—Epirubicin—ovarian cancer	0.000161	0.000688	CcSEcCtD
Gadoxetate—Back pain—Doxorubicin—ovarian cancer	0.00016	0.000687	CcSEcCtD
Gadoxetate—Headache—Paclitaxel—ovarian cancer	0.00016	0.000686	CcSEcCtD
Gadoxetate—Hypersensitivity—Docetaxel—ovarian cancer	0.00016	0.000684	CcSEcCtD
Gadoxetate—Palpitations—Epirubicin—ovarian cancer	0.000158	0.000678	CcSEcCtD
Gadoxetate—Loss of consciousness—Epirubicin—ovarian cancer	0.000157	0.000675	CcSEcCtD
Gadoxetate—Cough—Epirubicin—ovarian cancer	0.000156	0.00067	CcSEcCtD
Gadoxetate—Vision blurred—Doxorubicin—ovarian cancer	0.000156	0.000669	CcSEcCtD
Gadoxetate—Asthenia—Docetaxel—ovarian cancer	0.000156	0.000666	CcSEcCtD
Gadoxetate—Convulsion—Epirubicin—ovarian cancer	0.000155	0.000665	CcSEcCtD
Gadoxetate—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000154	0.000659	CcSEcCtD
Gadoxetate—Pruritus—Docetaxel—ovarian cancer	0.000153	0.000657	CcSEcCtD
Gadoxetate—Chest pain—Epirubicin—ovarian cancer	0.000152	0.000653	CcSEcCtD
Gadoxetate—Agitation—Doxorubicin—ovarian cancer	0.000152	0.000653	CcSEcCtD
Gadoxetate—Anxiety—Epirubicin—ovarian cancer	0.000152	0.000651	CcSEcCtD
Gadoxetate—Nausea—Paclitaxel—ovarian cancer	0.000152	0.000651	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000151	0.000649	CcSEcCtD
Gadoxetate—ABCC4—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.000151	0.0355	CbGpPWpGaD
Gadoxetate—Discomfort—Epirubicin—ovarian cancer	0.000151	0.000646	CcSEcCtD
Gadoxetate—Malaise—Doxorubicin—ovarian cancer	0.000149	0.00064	CcSEcCtD
Gadoxetate—Dry mouth—Epirubicin—ovarian cancer	0.000149	0.000639	CcSEcCtD
Gadoxetate—Vertigo—Doxorubicin—ovarian cancer	0.000149	0.000638	CcSEcCtD
Gadoxetate—Syncope—Doxorubicin—ovarian cancer	0.000149	0.000637	CcSEcCtD
Gadoxetate—Diarrhoea—Docetaxel—ovarian cancer	0.000148	0.000635	CcSEcCtD
Gadoxetate—Palpitations—Doxorubicin—ovarian cancer	0.000146	0.000628	CcSEcCtD
Gadoxetate—Anaphylactic shock—Epirubicin—ovarian cancer	0.000146	0.000626	CcSEcCtD
Gadoxetate—Oedema—Epirubicin—ovarian cancer	0.000146	0.000626	CcSEcCtD
Gadoxetate—Loss of consciousness—Doxorubicin—ovarian cancer	0.000146	0.000624	CcSEcCtD
Gadoxetate—Infection—Epirubicin—ovarian cancer	0.000145	0.000622	CcSEcCtD
Gadoxetate—Cough—Doxorubicin—ovarian cancer	0.000145	0.00062	CcSEcCtD
Gadoxetate—Shock—Epirubicin—ovarian cancer	0.000144	0.000616	CcSEcCtD
Gadoxetate—Convulsion—Doxorubicin—ovarian cancer	0.000144	0.000615	CcSEcCtD
Gadoxetate—Nervous system disorder—Epirubicin—ovarian cancer	0.000143	0.000614	CcSEcCtD
Gadoxetate—Dizziness—Docetaxel—ovarian cancer	0.000143	0.000614	CcSEcCtD
Gadoxetate—Tachycardia—Epirubicin—ovarian cancer	0.000143	0.000611	CcSEcCtD
Gadoxetate—Skin disorder—Epirubicin—ovarian cancer	0.000142	0.000608	CcSEcCtD
Gadoxetate—Hyperhidrosis—Epirubicin—ovarian cancer	0.000141	0.000606	CcSEcCtD
Gadoxetate—Chest pain—Doxorubicin—ovarian cancer	0.000141	0.000605	CcSEcCtD
Gadoxetate—Anxiety—Doxorubicin—ovarian cancer	0.000141	0.000602	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00014	0.0006	CcSEcCtD
Gadoxetate—Discomfort—Doxorubicin—ovarian cancer	0.000139	0.000597	CcSEcCtD
Gadoxetate—Anorexia—Epirubicin—ovarian cancer	0.000139	0.000597	CcSEcCtD
Gadoxetate—Dry mouth—Doxorubicin—ovarian cancer	0.000138	0.000591	CcSEcCtD
Gadoxetate—Vomiting—Docetaxel—ovarian cancer	0.000138	0.00059	CcSEcCtD
Gadoxetate—Rash—Docetaxel—ovarian cancer	0.000137	0.000586	CcSEcCtD
Gadoxetate—Hypotension—Epirubicin—ovarian cancer	0.000137	0.000585	CcSEcCtD
Gadoxetate—Dermatitis—Docetaxel—ovarian cancer	0.000137	0.000585	CcSEcCtD
Gadoxetate—Headache—Docetaxel—ovarian cancer	0.000136	0.000582	CcSEcCtD
Gadoxetate—Oedema—Doxorubicin—ovarian cancer	0.000135	0.00058	CcSEcCtD
Gadoxetate—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000135	0.00058	CcSEcCtD
Gadoxetate—Infection—Doxorubicin—ovarian cancer	0.000134	0.000576	CcSEcCtD
Gadoxetate—Shock—Doxorubicin—ovarian cancer	0.000133	0.00057	CcSEcCtD
Gadoxetate—Nervous system disorder—Doxorubicin—ovarian cancer	0.000133	0.000568	CcSEcCtD
Gadoxetate—Tachycardia—Doxorubicin—ovarian cancer	0.000132	0.000566	CcSEcCtD
Gadoxetate—Skin disorder—Doxorubicin—ovarian cancer	0.000131	0.000563	CcSEcCtD
Gadoxetate—Paraesthesia—Epirubicin—ovarian cancer	0.000131	0.000562	CcSEcCtD
Gadoxetate—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000131	0.00056	CcSEcCtD
Gadoxetate—Dyspnoea—Epirubicin—ovarian cancer	0.00013	0.000558	CcSEcCtD
Gadoxetate—Anorexia—Doxorubicin—ovarian cancer	0.000129	0.000552	CcSEcCtD
Gadoxetate—Nausea—Docetaxel—ovarian cancer	0.000129	0.000552	CcSEcCtD
Gadoxetate—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.000127	0.0299	CbGpPWpGaD
Gadoxetate—Decreased appetite—Epirubicin—ovarian cancer	0.000127	0.000545	CcSEcCtD
Gadoxetate—Hypotension—Doxorubicin—ovarian cancer	0.000126	0.000542	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000126	0.000541	CcSEcCtD
Gadoxetate—Fatigue—Epirubicin—ovarian cancer	0.000126	0.00054	CcSEcCtD
Gadoxetate—Constipation—Epirubicin—ovarian cancer	0.000125	0.000536	CcSEcCtD
Gadoxetate—Paraesthesia—Doxorubicin—ovarian cancer	0.000121	0.00052	CcSEcCtD
Gadoxetate—Dyspnoea—Doxorubicin—ovarian cancer	0.000121	0.000517	CcSEcCtD
Gadoxetate—Feeling abnormal—Epirubicin—ovarian cancer	0.00012	0.000516	CcSEcCtD
Gadoxetate—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.00012	0.0281	CbGpPWpGaD
Gadoxetate—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00012	0.000512	CcSEcCtD
Gadoxetate—Decreased appetite—Doxorubicin—ovarian cancer	0.000118	0.000504	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000117	0.0005	CcSEcCtD
Gadoxetate—Fatigue—Doxorubicin—ovarian cancer	0.000117	0.0005	CcSEcCtD
Gadoxetate—Urticaria—Epirubicin—ovarian cancer	0.000116	0.000498	CcSEcCtD
Gadoxetate—Constipation—Doxorubicin—ovarian cancer	0.000116	0.000496	CcSEcCtD
Gadoxetate—Abdominal pain—Epirubicin—ovarian cancer	0.000116	0.000495	CcSEcCtD
Gadoxetate—Body temperature increased—Epirubicin—ovarian cancer	0.000116	0.000495	CcSEcCtD
Gadoxetate—Feeling abnormal—Doxorubicin—ovarian cancer	0.000111	0.000478	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000111	0.000474	CcSEcCtD
Gadoxetate—Hypersensitivity—Epirubicin—ovarian cancer	0.000108	0.000461	CcSEcCtD
Gadoxetate—Urticaria—Doxorubicin—ovarian cancer	0.000107	0.00046	CcSEcCtD
Gadoxetate—ABCC2—Irinotecan Pathway—APC—ovarian cancer	0.000107	0.0252	CbGpPWpGaD
Gadoxetate—Body temperature increased—Doxorubicin—ovarian cancer	0.000107	0.000458	CcSEcCtD
Gadoxetate—Abdominal pain—Doxorubicin—ovarian cancer	0.000107	0.000458	CcSEcCtD
Gadoxetate—Asthenia—Epirubicin—ovarian cancer	0.000105	0.000449	CcSEcCtD
Gadoxetate—Pruritus—Epirubicin—ovarian cancer	0.000103	0.000443	CcSEcCtD
Gadoxetate—SLCO1B1—Irinotecan Pathway—APC—ovarian cancer	0.000101	0.0236	CbGpPWpGaD
Gadoxetate—Diarrhoea—Epirubicin—ovarian cancer	0.0001	0.000429	CcSEcCtD
Gadoxetate—Hypersensitivity—Doxorubicin—ovarian cancer	9.97e-05	0.000427	CcSEcCtD
Gadoxetate—Asthenia—Doxorubicin—ovarian cancer	9.7e-05	0.000416	CcSEcCtD
Gadoxetate—ABCC3—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	9.7e-05	0.0227	CbGpPWpGaD
Gadoxetate—Dizziness—Epirubicin—ovarian cancer	9.67e-05	0.000414	CcSEcCtD
Gadoxetate—Pruritus—Doxorubicin—ovarian cancer	9.57e-05	0.00041	CcSEcCtD
Gadoxetate—Vomiting—Epirubicin—ovarian cancer	9.29e-05	0.000398	CcSEcCtD
Gadoxetate—ABCC3—Fluoropyrimidine Activity—TYMS—ovarian cancer	9.29e-05	0.0218	CbGpPWpGaD
Gadoxetate—Diarrhoea—Doxorubicin—ovarian cancer	9.25e-05	0.000397	CcSEcCtD
Gadoxetate—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	9.24e-05	0.0217	CbGpPWpGaD
Gadoxetate—Rash—Epirubicin—ovarian cancer	9.22e-05	0.000395	CcSEcCtD
Gadoxetate—Dermatitis—Epirubicin—ovarian cancer	9.21e-05	0.000395	CcSEcCtD
Gadoxetate—Headache—Epirubicin—ovarian cancer	9.16e-05	0.000392	CcSEcCtD
Gadoxetate—Dizziness—Doxorubicin—ovarian cancer	8.94e-05	0.000383	CcSEcCtD
Gadoxetate—ABCC3—ABC-family proteins mediated transport—ABCB1—ovarian cancer	8.82e-05	0.0207	CbGpPWpGaD
Gadoxetate—ABCC4—Fluoropyrimidine Activity—TYMS—ovarian cancer	8.73e-05	0.0205	CbGpPWpGaD
Gadoxetate—Nausea—Epirubicin—ovarian cancer	8.68e-05	0.000372	CcSEcCtD
Gadoxetate—Vomiting—Doxorubicin—ovarian cancer	8.6e-05	0.000368	CcSEcCtD
Gadoxetate—Rash—Doxorubicin—ovarian cancer	8.53e-05	0.000365	CcSEcCtD
Gadoxetate—Dermatitis—Doxorubicin—ovarian cancer	8.52e-05	0.000365	CcSEcCtD
Gadoxetate—Headache—Doxorubicin—ovarian cancer	8.47e-05	0.000363	CcSEcCtD
Gadoxetate—ABCC4—ABC-family proteins mediated transport—ABCB1—ovarian cancer	8.3e-05	0.0195	CbGpPWpGaD
Gadoxetate—Nausea—Doxorubicin—ovarian cancer	8.03e-05	0.000344	CcSEcCtD
Gadoxetate—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	7.69e-05	0.018	CbGpPWpGaD
Gadoxetate—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	7.32e-05	0.0172	CbGpPWpGaD
Gadoxetate—ABCC2—ABC-family proteins mediated transport—ABCB1—ovarian cancer	7e-05	0.0164	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—SPARC—ovarian cancer	6.52e-05	0.0153	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—SPARC—ovarian cancer	6.22e-05	0.0146	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—HDAC6—ovarian cancer	5.23e-05	0.0123	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—SOD1—ovarian cancer	4.74e-05	0.0111	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—SOD1—ovarian cancer	4.52e-05	0.0106	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—SLC5A5—ovarian cancer	3.78e-05	0.00885	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—SLC2A1—ovarian cancer	3.65e-05	0.00855	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—SLC5A5—ovarian cancer	3.55e-05	0.00832	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—SLC2A1—ovarian cancer	3.43e-05	0.00804	CbGpPWpGaD
Gadoxetate—ABCC3—Fluoropyrimidine Activity—TP53—ovarian cancer	3.08e-05	0.00723	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—SLC5A5—ovarian cancer	2.99e-05	0.00702	CbGpPWpGaD
Gadoxetate—ABCC4—Fluoropyrimidine Activity—TP53—ovarian cancer	2.9e-05	0.00679	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—SPARC—ovarian cancer	2.89e-05	0.00679	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—SLC2A1—ovarian cancer	2.89e-05	0.00678	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—RAD51C—ovarian cancer	2.79e-05	0.00655	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—AQP3—ovarian cancer	2.65e-05	0.00621	CbGpPWpGaD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	2.64e-05	0.00618	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	2.62e-05	0.00614	CbGpPWpGaD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	2.55e-05	0.00597	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ATP7B—ovarian cancer	2.54e-05	0.00596	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—AQP3—ovarian cancer	2.39e-05	0.00561	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	2.36e-05	0.00554	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ATP7B—ovarian cancer	2.29e-05	0.00538	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—AQP3—ovarian cancer	2.25e-05	0.00527	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ATP7B—ovarian cancer	2.16e-05	0.00505	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—SOD1—ovarian cancer	2.1e-05	0.00493	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—NME2—ovarian cancer	2.07e-05	0.00486	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—TUBB3—ovarian cancer	2.01e-05	0.00471	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—AQP3—ovarian cancer	1.9e-05	0.00445	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—VEGFA—ovarian cancer	1.89e-05	0.00443	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—NME2—ovarian cancer	1.87e-05	0.00438	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	1.82e-05	0.00426	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—TUBB3—ovarian cancer	1.81e-05	0.00425	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—ovarian cancer	1.8e-05	0.00422	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—AQP3—ovarian cancer	1.78e-05	0.00418	CbGpPWpGaD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	1.77e-05	0.00415	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	1.76e-05	0.00413	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.76e-05	0.00412	CbGpPWpGaD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	1.71e-05	0.00401	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	1.71e-05	0.004	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—TUBB3—ovarian cancer	1.7e-05	0.004	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.59e-05	0.00372	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—SPARC—ovarian cancer	1.49e-05	0.0035	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	1.44e-05	0.00337	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.43e-05	0.00336	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	1.4e-05	0.00328	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NME2—ovarian cancer	1.39e-05	0.00326	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—CTNNB1—ovarian cancer	1.39e-05	0.00325	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	1.35e-05	0.00316	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.34e-05	0.00314	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYTB—ovarian cancer	1.34e-05	0.00313	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.3e-05	0.00306	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.29e-05	0.00303	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.29e-05	0.00303	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	1.23e-05	0.00289	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.21e-05	0.00284	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYTB—ovarian cancer	1.2e-05	0.00282	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.18e-05	0.00277	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.18e-05	0.00276	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.17e-05	0.00274	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—BRIP1—ovarian cancer	1.17e-05	0.00274	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PPP1CC—ovarian cancer	1.17e-05	0.00274	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.14e-05	0.00267	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—MYC—ovarian cancer	1.12e-05	0.00263	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.1e-05	0.00257	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—SOD1—ovarian cancer	1.08e-05	0.00254	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PPP2R1A—ovarian cancer	1.08e-05	0.00253	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	1.07e-05	0.00252	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PPP1CC—ovarian cancer	1.05e-05	0.00247	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—BRIP1—ovarian cancer	1.05e-05	0.00247	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.02e-05	0.0024	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—IL2—ovarian cancer	9.85e-06	0.00231	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	9.63e-06	0.00226	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	9.59e-06	0.00225	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	9.26e-06	0.00217	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	9.22e-06	0.00216	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	9e-06	0.00211	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYTB—ovarian cancer	8.97e-06	0.0021	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	8.77e-06	0.00206	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	8.7e-06	0.00204	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ABCB1—ovarian cancer	8.67e-06	0.00203	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	8.5e-06	0.00199	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	8.37e-06	0.00196	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—CAV1—ovarian cancer	7.92e-06	0.00186	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	7.92e-06	0.00186	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—BRIP1—ovarian cancer	7.84e-06	0.00184	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PPP1CC—ovarian cancer	7.84e-06	0.00184	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—YAP1—ovarian cancer	7.83e-06	0.00184	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.75e-06	0.00182	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	7.67e-06	0.0018	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	7.54e-06	0.00177	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	7.31e-06	0.00171	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CG—ovarian cancer	7.22e-06	0.00169	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—YAP1—ovarian cancer	7.06e-06	0.00166	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.99e-06	0.00164	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	6.87e-06	0.00161	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.81e-06	0.0016	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	6.54e-06	0.00153	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—FASN—ovarian cancer	6.38e-06	0.0015	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CD—ovarian cancer	6.35e-06	0.00149	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SLC5A5—ovarian cancer	6.28e-06	0.00147	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.14e-06	0.00144	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SLC2A1—ovarian cancer	6.06e-06	0.00142	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.94e-06	0.00139	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP1B1—ovarian cancer	5.81e-06	0.00136	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—FASN—ovarian cancer	5.76e-06	0.00135	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.71e-06	0.00134	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SLC5A5—ovarian cancer	5.66e-06	0.00133	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CB—ovarian cancer	5.53e-06	0.0013	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SLC2A1—ovarian cancer	5.47e-06	0.00128	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.36e-06	0.00126	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	5.34e-06	0.00125	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—YAP1—ovarian cancer	5.26e-06	0.00123	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP1B1—ovarian cancer	5.24e-06	0.00123	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.2e-06	0.00122	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PPP2R1A—ovarian cancer	5.15e-06	0.00121	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.13e-06	0.0012	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IL2—ovarian cancer	5.08e-06	0.00119	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ABCB1—ovarian cancer	4.79e-06	0.00112	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—TYMS—ovarian cancer	4.7e-06	0.0011	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PPP2R1A—ovarian cancer	4.65e-06	0.00109	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.63e-06	0.00109	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.58e-06	0.00107	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ABCB1—ovarian cancer	4.32e-06	0.00101	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—VEGFA—ovarian cancer	4.32e-06	0.00101	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—FASN—ovarian cancer	4.29e-06	0.00101	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—NRAS—ovarian cancer	4.26e-06	0.001	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—TYMS—ovarian cancer	4.24e-06	0.000994	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SLC5A5—ovarian cancer	4.22e-06	0.000989	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—MAPK3—ovarian cancer	4.08e-06	0.000958	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SLC2A1—ovarian cancer	4.07e-06	0.000955	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.99e-06	0.000935	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP1B1—ovarian cancer	3.9e-06	0.000916	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—MAPK1—ovarian cancer	3.89e-06	0.000911	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CAV1—ovarian cancer	3.79e-06	0.000888	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—KRAS—ovarian cancer	3.67e-06	0.000861	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.62e-06	0.000848	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PPP2R1A—ovarian cancer	3.46e-06	0.000812	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CG—ovarian cancer	3.45e-06	0.000809	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.45e-06	0.000808	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CAV1—ovarian cancer	3.42e-06	0.000801	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CA—ovarian cancer	3.37e-06	0.000791	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.26e-06	0.000766	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—TP53—ovarian cancer	3.26e-06	0.000765	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ABCB1—ovarian cancer	3.22e-06	0.000754	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—TYMS—ovarian cancer	3.16e-06	0.000741	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—HRAS—ovarian cancer	3.12e-06	0.000731	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CG—ovarian cancer	3.11e-06	0.00073	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CD—ovarian cancer	3.03e-06	0.000711	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—AKT1—ovarian cancer	2.75e-06	0.000646	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CD—ovarian cancer	2.74e-06	0.000642	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CB—ovarian cancer	2.64e-06	0.00062	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CAV1—ovarian cancer	2.54e-06	0.000597	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.43e-06	0.00057	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CB—ovarian cancer	2.39e-06	0.000559	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	2.32e-06	0.000544	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PTEN—ovarian cancer	2.28e-06	0.000536	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PTEN—ovarian cancer	2.06e-06	0.000483	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	2.04e-06	0.000478	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	1.78e-06	0.000416	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CA—ovarian cancer	1.61e-06	0.000378	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PTEN—ovarian cancer	1.53e-06	0.00036	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CA—ovarian cancer	1.45e-06	0.000341	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AKT1—ovarian cancer	1.32e-06	0.000309	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AKT1—ovarian cancer	1.19e-06	0.000279	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	1.08e-06	0.000254	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—AKT1—ovarian cancer	8.84e-07	0.000207	CbGpPWpGaD
